CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 60 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $13,000 | -23.5% | 2,623 | 0.0% | 0.00% | – |
Q2 2021 | $17,000 | -15.0% | 2,623 | 0.0% | 0.00% | – |
Q1 2021 | $20,000 | +17.6% | 2,623 | 0.0% | 0.00% | – |
Q4 2020 | $17,000 | 0.0% | 2,623 | 0.0% | 0.00% | – |
Q3 2020 | $17,000 | -22.7% | 2,623 | 0.0% | 0.00% | – |
Q2 2020 | $22,000 | +10.0% | 2,623 | 0.0% | 0.00% | – |
Q1 2020 | $20,000 | -9.1% | 2,623 | 0.0% | 0.00% | – |
Q4 2019 | $22,000 | -60.0% | 2,623 | -46.9% | 0.00% | – |
Q2 2019 | $55,000 | +3.8% | 4,943 | 0.0% | 0.00% | – |
Q1 2019 | $53,000 | -26.4% | 4,943 | 0.0% | 0.00% | – |
Q4 2018 | $72,000 | -20.9% | 4,943 | 0.0% | 0.00% | – |
Q3 2018 | $91,000 | -19.5% | 4,943 | 0.0% | 0.00% | – |
Q2 2018 | $113,000 | +121.6% | 4,943 | +174.6% | 0.00% | – |
Q1 2018 | $51,000 | +34.2% | 1,800 | 0.0% | 0.00% | – |
Q4 2017 | $38,000 | +18.8% | 1,800 | 0.0% | 0.00% | – |
Q3 2017 | $32,000 | +14.3% | 1,800 | 0.0% | 0.00% | – |
Q2 2017 | $28,000 | -9.7% | 1,800 | 0.0% | 0.00% | – |
Q1 2017 | $31,000 | +55.0% | 1,800 | 0.0% | 0.00% | – |
Q4 2016 | $20,000 | -64.3% | 1,800 | -50.0% | 0.00% | – |
Q3 2016 | $56,000 | +211.1% | 3,600 | +100.0% | 0.00% | – |
Q2 2016 | $18,000 | – | 1,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |